Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.52 |
| ▸ | THRA | P10827 | 5/20 | 0.49 |
| ▸ | THRB | P10828 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | DGKA | P23743 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.42 |
| ▸ | KDM5A | P29375 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31245954 | 1.00 | DNM1 (0.52) | DNM1THRATHRBMAPTDGKA | |
| SCHEMBL31245863 | 0.99 | DNM1 (0.51) | DNM1THRATHRBMAPTDGKA | |
| SCHEMBL22767923 | 0.96 | DNM1 (0.47) | DNM1THRATHRBMAPTDGKA | |
| SCHEMBL31245934 | 0.90 | THRA (0.49) | DNM1THRATHRBKDM5AHPGD | |
| SCHEMBL20198772 | 0.90 | THRA (0.48) | DNM1THRATHRBMAPTEPHX2 | |
| SCHEMBL31245975 | 0.89 | THRA (0.42) | DNM1THRATHRBMAPTEPHX2 | |
| SCHEMBL27329014 | 0.89 | DGKA (0.50) | DNM1THRATHRBMAPTDGKA | |
| SCHEMBL27329439 | 0.88 | DGKA (0.49) | DNM1THRATHRBMAPTDGKA | |
| SCHEMBL31246008 | 0.85 | THRA (0.45) | DNM1THRATHRBKDM5AHPGD | |
| SCHEMBL25232569 | 0.84 | THRA (0.40) | DNM1THRATHRBEPHX2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |